Patent ID: 6432399
Filing Date: 2002-08-13
Classification: A61K

Abstract:
A process of preconditioning a mammalian patient at risk of myocardial infarction as a consequence of unstable angina which comprises:selecting a patient suffering from unstable angina; subjecting an aliquot of compatible mammalian blood extracorporeally to at least one stressor selected from the group of stressors consisting of: an oxidative environment equivalent to that generated by passing through the blood aliquot a medical grade oxygen/ozone gas mixture containing 0.1-100 g/ml ozone; UV radiation; and elevated temperature up to about 45Â° C.; and subsequently administering the aliquot of stressed blood to said patient, thereby conditioning the patient to better withstand subsequently experienced myocardial infarction with resulting reduced infarct size.